Vitality Re VIII Ltd

Share

Aetna’s medical benefit ratio drops further below Vitality Re ILS trigger in Q2

For the second-quarter of 2020, the medical benefit claims ratio reported by CVS-owned health insurer Aetna dropped even further below levels where its Vitality Re series of health insurance-linked securities (ILS) transactions could be triggered. This is despite the impacts of the Covid-19 coronavirus pandemic, which might have been thought a read the full article →

Aetna’s claim ratio well-below Vitality Re ILS trigger in Q1 despite Covid-19

Despite the impacts of the Covid-19 coronavirus pandemic, the medical benefit claims ratio reported by insurer Aetna for the first-quarter of 2020 has remained well-below the levels where its Vitality Re series of health insurance-linked securities (ILS) transactions could be triggered, we can report. As we'd explained previously, the Vitality Re read the full article →

Vitality Re health ILS all discounted in secondary market on Covid-19

The secondary market prices for the Vitality Re series of health insurance-linked securities (ILS) transactions have all been discounted on the potential for the ongoing Covid-19 coronavirus pandemic to drive an elevated level of medical benefit claims through to insurer and sponsor Aetna. As we explained more than a week ago, read the full article →

Vitality Re health ILS at risk from coronavirus morbidity stress: S&P

The Vitality Re series of health insurance-linked securities (ILS) transactions, which provide reinsurance protection to health insurer Aetna, are exposed to potential triggering by the coronavirus pandemic should it result in "severe morbidity stress", rating agency S&P has said. The Vitality Re series of health ILS transactions are a way for read the full article →

Aetna closes $200m Vitality Re IX health insurance-linked securities deal

Health care benefits insurer Aetna has successfully completed its ninth capital markets backed reinsurance arrangement through a $200 million issuance of health insurance-linked securities (ILS), in the Vitality Re IX Ltd. (Series 2018-1) transaction. The issuance was completed using newly established Cayman Islands special purpose vehicle Vitality Re IX Ltd. which read the full article →

Vitality Re IX health ILS from Aetna priced below guidance

The $200 million Vitality Re IX Ltd. (Series 2018-1) health insurance-linked securities (ILS) transaction from Aetna has now been priced and both tranches of notes have had their coupons fixed at levels below the bottom-end of the initial price guidance ranges. The Vitality Re series of health insurance ILS transactions are read the full article →

Vitality Re IX pricing delayed on health insurer fee uncertainty

Pricing for the in-the-market $200 million Vitality Re IX Ltd. (Series 2018-1) health insurance-linked securities (ILS) issuance has been delayed due to uncertainty over the future of health insurer fees, because the U.S. government has been considering the fees as part of government shutdown related budgetary debates. The so-called anti-shutdown bill, read the full article →

Vitality Re IX $200m health ILS from Aetna the first deal of 2018

A new health insurance-linked securities (ILS) transaction from Aetna is the first cat bond or ILS transaction to launch and be listed in our Deal Directory in 2018, with a $200 million Vitality Re IX Ltd. (Series 2018-1) that will secure reinsurance protection against a deterioration of the insurers' medical read the full article →

Aetna hails how eighth Vitality Re ILS enhances its capital position

Health insurance company Aetna said that its successful eighth Vitality Re health insurance linked securitisation transaction, the $200 million Vitality Re VIII Ltd. (Series 2017-1), contributes to an enhanced capital position for the firm. The successful execution of the Vitality Re VIII transaction, and sale of the notes issued to investors, now read the full article →

Vitality Re VIII health ILS prices at low end of guidance for Aetna

Aetna's latest and eighth medical benefit claims insurance-linked security (ILS) transaction, Vitality Re VIII Ltd. (Series 2017-1), has now been priced at the low end of coupon guidance, once again reflecting investor demand for these very remote health insurance related risks. Aetna has consistently seen its Vitality Re ILS transactions, where read the full article →